Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru

Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China

(2013) Chun-fang Ma et al.   BMC INFECTIOUS DISEASES

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

(2013) M.C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey

(2013) Marcio Nucci et al.   PLoS One

In VitroFluconazole and Voriconazole Susceptibilities ofCandidaBloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values

(2013) Min Joong Jang et al.   Annals of Laboratory Medicine

Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011

(2012) A. A. Cleveland et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

(2012) J. Peman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

(2012) S. R. Lockhart et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Ten-Year Study of Species Distribution and Antifungal Susceptibilities of Candida Bloodstream Isolates at a Brazilian Tertiary Hospital

(2012) L. X. Bonfietti et al.   MYCOPATHOLOGIA

Susceptibilidad a azoles y anfotericina B de aislados de Candida spp: Experiencia de una red de salud universitaria,entre 2004 y 2010

(2012) Lorena Porte et al.   Revista Chilena de Infectologia

Frequency of Voriconazole ResistanceIn Vitroamong Spanish Clinical Isolates ofCandidaspp. According to Breakpoints Established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing

(2011) M. Cuenca-Estrella et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital

(2011) I. Miranda-Zapico et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia

(2011) F. Amran et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Enfermedad fúngica invasora en pacientes de cinco hospitales de la Región de Valparaíso, Chile: 2004 a 2009

(2011) Rodrigo Cruz Ch et al.   Revista Chilena de Infectologia

Secular trends of candidemia in a tertiary care hospital

(2010) Thiago Zinsly Sampaio Camargo et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Epidemiologic surveillance of nosocomial infections in a Pediatric Intensive Care Unit of a developing country

(2010) María R Becerra et al.   BMC Pediatrics

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

(2010) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candidaspecies

(2010) Graziella H. Pereira et al.   MEDICAL MYCOLOGY

Multicenter surveillance of species distribution and antifungal susceptibilities ofCandidabloodstream isolates in South Korea

(2010) Sook-In Jung et al.   MEDICAL MYCOLOGY

Incidence, Etiology and Risk Factors Associated with Mortality of Nosocomial Candidemia in a Tertiary Care Hospital in Istanbul, Turkey

(2010) Ilknur Erdem et al.   MEDICAL PRINCIPLES AND PRACTICE

Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections

(2009) Ingi Lee et al.   ARCHIVES OF INTERNAL MEDICINE

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

(2008) S. R. Lockhart et al.   JOURNAL OF CLINICAL MICROBIOLOGY